Free Trial

Aspire Biopharma (ASBP) Competitors

Aspire Biopharma logo
$0.58 +0.02 (+3.36%)
As of 04:00 PM Eastern

ASBP vs. ANEB, MGNX, SAVA, TCRX, ANRO, SPRO, HLVX, CNTB, SKYE, and ONCY

Should you be buying Aspire Biopharma stock or one of its competitors? The main competitors of Aspire Biopharma include Anebulo Pharmaceuticals (ANEB), MacroGenics (MGNX), Cassava Sciences (SAVA), TScan Therapeutics (TCRX), Alto Neuroscience (ANRO), Spero Therapeutics (SPRO), HilleVax (HLVX), Connect Biopharma (CNTB), Skye Bioscience (SKYE), and Oncolytics Biotech (ONCY). These companies are all part of the "pharmaceutical products" industry.

Aspire Biopharma vs. Its Competitors

Anebulo Pharmaceuticals (NASDAQ:ANEB) and Aspire Biopharma (NASDAQ:ASBP) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

Aspire Biopharma's return on equity of 0.00% beat Anebulo Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Anebulo PharmaceuticalsN/A -90.11% -84.53%
Aspire Biopharma N/A N/A -737.96%

Anebulo Pharmaceuticals has a beta of -0.88, meaning that its stock price is 188% less volatile than the S&P 500. Comparatively, Aspire Biopharma has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

28.4% of Anebulo Pharmaceuticals shares are held by institutional investors. Comparatively, 19.2% of Aspire Biopharma shares are held by institutional investors. 80.6% of Anebulo Pharmaceuticals shares are held by insiders. Comparatively, 48.0% of Aspire Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Anebulo PharmaceuticalsN/AN/A-$8.20M-$0.26-9.62
Aspire BiopharmaN/AN/A-$12.54MN/AN/A

In the previous week, Anebulo Pharmaceuticals and Anebulo Pharmaceuticals both had 1 articles in the media. Anebulo Pharmaceuticals' average media sentiment score of 1.87 beat Aspire Biopharma's score of 1.64 indicating that Anebulo Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
Anebulo Pharmaceuticals Very Positive
Aspire Biopharma Very Positive

Anebulo Pharmaceuticals presently has a consensus target price of $5.50, suggesting a potential upside of 120.00%. Given Anebulo Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Anebulo Pharmaceuticals is more favorable than Aspire Biopharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anebulo Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Aspire Biopharma
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Anebulo Pharmaceuticals beats Aspire Biopharma on 8 of the 10 factors compared between the two stocks.

Get Aspire Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASBP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASBP vs. The Competition

MetricAspire BiopharmaMED IndustryMedical SectorNASDAQ Exchange
Market Cap$28.50M$3.08B$5.76B$9.75B
Dividend YieldN/A2.26%3.96%4.02%
P/E RatioN/A20.9242.8226.39
Price / SalesN/A355.43431.37159.28
Price / CashN/A44.7137.7559.42
Price / Book-3.038.0410.566.59
Net Income-$12.54M-$53.98M$3.27B$265.83M
7 Day Performance5.35%-0.88%0.61%0.18%
1 Month Performance20.76%5.67%5.43%2.13%
1 Year PerformanceN/A9.07%50.37%21.07%

Aspire Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASBP
Aspire Biopharma
N/A$0.58
+3.4%
N/AN/A$28.50MN/A0.00N/APositive News
Gap Up
ANEB
Anebulo Pharmaceuticals
2.313 of 5 stars
$2.60
+5.7%
$5.50
+111.5%
+38.0%$106.82MN/A0.004Positive News
MGNX
MacroGenics
4.3368 of 5 stars
$1.69
+17.4%
$3.60
+113.0%
-50.7%$106.82M$149.96M0.00430High Trading Volume
SAVA
Cassava Sciences
1.7009 of 5 stars
$2.20
+2.3%
$2.00
-9.1%
-91.1%$106.28MN/A0.0030
TCRX
TScan Therapeutics
3.4142 of 5 stars
$1.87
+7.5%
$7.80
+317.1%
-68.0%$105.83M$2.82M0.00100
ANRO
Alto Neuroscience
1.8077 of 5 stars
$3.91
+8.8%
$8.50
+117.6%
-67.8%$105.60MN/A0.00N/A
SPRO
Spero Therapeutics
4.0369 of 5 stars
$1.87
+0.5%
$5.00
+167.4%
+46.0%$105.23M$47.98M0.00150
HLVX
HilleVax
1.8925 of 5 stars
$2.06
-0.5%
$2.00
-2.9%
+8.9%$103.29MN/A0.0020
CNTB
Connect Biopharma
3.2922 of 5 stars
$1.83
+5.8%
$7.00
+282.5%
+72.5%$101.97M$26.03M0.00110Upcoming Earnings
SKYE
Skye Bioscience
1.6257 of 5 stars
$3.29
-7.3%
$15.50
+371.1%
-42.7%$101.95MN/A0.0011
ONCY
Oncolytics Biotech
1.7586 of 5 stars
$1.01
flat
$5.00
+395.0%
+11.5%$101.36MN/A0.0030

Related Companies and Tools


This page (NASDAQ:ASBP) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners